The Vanguard Group, Inc. recently announced the acquisition of new stake in DENTSPLY Sirona Inc (NASDAQ:XRAY). The institutional investor has increased its shareholding in the Healthcare company by 1.50% to 24.37 million shares with purchase of 0.36 million shares. This fresh investment now brings its stake to 11.50% valued currently at $773.69 million. In addition, BlackRock Fund Advisors raised its holdings by 58635.0 to 11.18 million shares. And Cooke & Bieler LP has lifted its position by 12.80% or 0.68 million shares – to 5.97 million shares.
With over 4.4 million DENTSPLY Sirona Inc (XRAY) shares trading Tuesday and a closing price of $36.53 on the day, the dollar volume was approximately $160.72 million. The shares have shown a negative half year performance of -9.76% and its price on 01/09/24 gained nearly 1.75%. Currently, there are 215.30M common shares owned by the public and among those 209.90M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 15 analysts who have offered their price forecasts for XRAY have a consensus price objective of $36.42. The analysts have set the share’s price value over the next 12 months at a high of $42.00 and a low of $30.00. The average price target is -1.95% below its recent price level and a downside to the estimated low will see the stock lose -21.77% over that period. But an upside of 13.02% will see the stock hit the forecast high price target while median target price for the stock is $38.00.
Insiders at the company have transacted a total of 108 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 94 of these insider trades were purchases, accounting for 218,138 shares. Insider sales of the common stock occurred on 14 occasions, with total insider shares sold totaling 63,067 shares.
The top 3 mutual fund holders in DENTSPLY Sirona Inc are First Eagle Global Fund, Vanguard Total Stock Market ETF, and Nuance Mid Cap Value Fund. First Eagle Global Fund owns 6.9 million shares of the company’s stock, all valued at over $219.11 million. Vanguard Total Stock Market ETF bought 8023.0 shares to see its total holdings expand to 6.63 million shares valued at over $210.55 million and representing 3.13% of the shares outstanding. Nuance Mid Cap Value Fund bought 1.64 million shares to bring its total holdings to over 6.03 million shares at a value of $191.61 million. Nuance Mid Cap Value Fund now owns shares totaling to 2.85% of the shares outstanding.
Shares of DENTSPLY Sirona Inc (NASDAQ: XRAY) opened at $35.80, down -$0.1 from a prior closing price of $35.90. However, the script later moved the day high at 37.19, up 1.75%. The company’s stock has a 5-day price change of 2.53% and 14.30% over the past three months. XRAY shares are trading 2.64% year to date (YTD), with the 12-month market performance up to 9.27% higher. It has a 12-month low price of $26.27 and touched a high of $43.24 over the same period. XRAY has an average intraday trading volume of 3.50 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.80%, 14.28%, and 0.04% respectively.
Institutional ownership of DENTSPLY Sirona Inc (NASDAQ: XRAY) shares accounts for 98.56% of the company’s 215.30M shares outstanding. Mutual fund holders own 40.40%, while other institutional holders and individual stakeholders account for 58.36% and 2.00% respectively.
It has a market capitalization of $7.74B and a beta (3y monthly) value of 1.02. The earnings-per-share (ttm) stands at -$1.01. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.97% over the week and 2.38% over the month.
Analysts forecast that DENTSPLY Sirona Inc (XRAY) will achieve an EPS of $Accuray Incorporated for the current quarter, $2.78 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $NEOS ETF Trust FIS Christian St while analysts give the company a high EPS estimate of $XRA. Comparatively, EPS for the current quarter was $CRAY a year ago. Earnings per share for the fiscal year are expected to decrease by -12.78%, and 12.03% over the next financial year. EPS should shrink at an annualized rate of 8.00% over the next five years, compared to 8.19% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 15 brokerage firm advisors rate DENTSPLY Sirona Inc (XRAY) as a “Moderate Buy” at a consensus score of 2.07. Specifically, 7 Wall Street analysts polled rate the stock as a buy, while 8 of the 15 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the XRAY, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on November 16, 2023, with the firm’s price target at $35.
